Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
16 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Cel-Sci Corporation’s names, not what it holds today.
Patents granted
16
16 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
11
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'00'01'03'05'06'07'08'11'12'13'14'15'16'19'21
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Cel-Sci Corporation its own name
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in AT)
10 publishedCEL-SCI CORPORATION its own name
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jun 22, 2021 | 11,041,013 | Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis | Pharmaceuticals | Cel-Sci Corporation |
| Mar 26, 2019 | 10,238,747 | Method for inducing an immune response against avian, swine, spanish, H1N1, H5N9 influenza viruses and formulations thereof | Pharmaceuticals | Cel-Sci Corporation |
| Jan 15, 2019 | 10,179,174 | Method for inducing an immune response and formulations thereof | Pharmaceuticals | Cel-Sci Corporation |
| Jan 15, 2019 | 10,179,164 | Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions | Pharmaceuticals | Cel-Sci Corporation |
| Aug 14, 2007 | 7,256,254 | Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions | Pharmaceuticals | Cel-Sci Corporation |
| Apr 3, 2007 | 7,199,216 | Peptide constructs for treating autoimmune and related diseases | Pharmaceuticals | Cel-Sci Corporation |
| Feb 7, 2006 | 6,995,237 | Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions | Biotechnology | Cel-Sci Corporation |
| Oct 4, 2005 | 6,951,647 | T cell binding ligand peptides and method of inducing a cellular immune response | Pharmaceuticals | Cel-Sci Corporation |
| May 24, 2005 | 6,896,879 | Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture | Pharmaceuticals | Cel-Sci Corporation |
| Jun 3, 2003 | 6,572,860 | Immunogenic conjugated polypeptide for treatment of herpes simplex virus | Biotechnology | Cel-Sci Corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Sep 2, 2021 | 2021/0268101 | NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-nCoV INFECTIONS | Pharmaceuticals | CEL-SCI CORPORATION |
| Jun 9, 2016 | 2016/0158330 | METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS | Medical technology | Cel-Sci Corporation |
| May 21, 2015 | 2015/0140065 | METHOD FOR INDUCING AN IMMUNE RESPONSE AND FORMULATIONS THEREOF | Pharmaceuticals | Cel-Sci Corporation · patent 10,179,174 granted from it |
| Sep 25, 2014 | 2014/0286858 | METHOD FOR INDUCING AN IMMUNE RESPONSE FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASES OR CONDITIONS | Pharmaceuticals | Cel-Sci Corporation · patent 10,179,164 granted from it |
| Oct 10, 2013 | 2013/0266599 | METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST AVIAN, SWINE, SPANISH, H1N1, H5N9 INFLUENZA VIRUSES AND FORMULATIONS THEREOF | Pharmaceuticals | Cel-Sci Corporation · patent 10,238,747 granted from it |
| Feb 16, 2012 | 2012/0039926 | Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells | Pharmaceuticals | Cel-Sci Corporation |
| Apr 28, 2011 | 2011/0098444 | METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS | Pharmaceuticals | Cel-Sci Corporation · patent 11,041,013 granted from it |
| Jun 5, 2008 | 2008/0131396 | Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor | Pharmaceuticals | Cel-Sci Corporation |
| Mar 13, 2008 | 2008/0063625 | Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine Mixture | Pharmaceuticals | Cel-Sci Corporation |
| Nov 16, 2006 | 2006/0257420 | Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions | Pharmaceuticals | Cel-Sci Corporation |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.